| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/06/2004 | WO2004037860A1 Epididymis-specific gene as potential contraceptive target |
| 05/06/2004 | WO2004037859A1 Glp-1 derivatives and transmicosal absorption preparations thereof |
| 05/06/2004 | WO2004037858A2 Nipa, a nuclear interacting partner of anaplastic lymphoma kinase, polypeptides and use thereof |
| 05/06/2004 | WO2004037857A1 Bfk protein as therapeutic molecules |
| 05/06/2004 | WO2004037856A2 Plasmodium falciparum virulence factor var o |
| 05/06/2004 | WO2004037847A2 Hiv envelope-cd4 complexes and hybrids |
| 05/06/2004 | WO2004037846A1 Immunisation against components of the human immunodeficiency virus (hiv) |
| 05/06/2004 | WO2004037797A2 2 - alkyl - (2 - amino - 3 - aryl - propionyl) - piperazine derivatives and related compounds as melanocortin receptor ligands for the treatment of obesity |
| 05/06/2004 | WO2004037297A1 Conjugates of tc complexes and targeting moieties and their use in mri diagnostic |
| 05/06/2004 | WO2004037294A2 New settings for recombinant adenoviral-based vaccines |
| 05/06/2004 | WO2004037283A1 Bowman-birk inhibitor concentrate product and process |
| 05/06/2004 | WO2004037278A2 Delocalization molecules and use thereof |
| 05/06/2004 | WO2004037205A2 LOW DOSE METHODS FOR TREATING DISORDERS IN WHICH TNFα ACTIVITY IS DETRIMENTAL |
| 05/06/2004 | WO2004037202A2 Gb virus c and methods of treating viral infections |
| 05/06/2004 | WO2004037195A2 Treatment of diabetes |
| 05/06/2004 | WO2004037192A2 Identification of antimycobacterial targets and the inhibition thereof as a treatment for infectious diseases |
| 05/06/2004 | WO2004037189A2 Methods for vaccinating against malaria |
| 05/06/2004 | WO2004037175A2 Compositions and methods for treating human papillomavirus-mediated disease |
| 05/06/2004 | WO2004023137A3 Method for screening for mutant virus movement proteins (mp) |
| 05/06/2004 | WO2004022755A3 Polypeptides involved in the regulation of flowering in forage grasses |
| 05/06/2004 | WO2004022700A3 Antifreeze proteins isolated from forage grasses and methods for their use |
| 05/06/2004 | WO2004022587A3 A pair of polypeptides with specific and strong interaction |
| 05/06/2004 | WO2004019976A3 Pharmaceutical liposomal compositions containing n. meningitidis derived polypeptides or polynucleotides |
| 05/06/2004 | WO2004016775A3 Plants having modified growth and a method for making the same |
| 05/06/2004 | WO2004016648A8 Fluorescent protein |
| 05/06/2004 | WO2004015113A3 Albumin-fused ciliary neurotrophic factor |
| 05/06/2004 | WO2004011676A3 Multi-reporter gene model for toxicological screening |
| 05/06/2004 | WO2004011018A3 Methods of identifying selective beta-1-adrenergic receptor antagonists |
| 05/06/2004 | WO2004009633A8 Serotonin receptor |
| 05/06/2004 | WO2004007536A3 Interactions of the epstein-barr virus protein ebna1, and uses thereof |
| 05/06/2004 | WO2004005334A3 Nucleic acid molecule encoding an allergen preprotein of a mite of genus dermatophagoides or euroglyphus and use thereof for protecting said allergen in plants |
| 05/06/2004 | WO2004004761A3 Adjuvant viral particle |
| 05/06/2004 | WO2004001068A3 Use of pp2a phosphatase modulators in the treatment of mental disorders |
| 05/06/2004 | WO2003104462A3 Regulation of gene expression using chromatin remodelling factors |
| 05/06/2004 | WO2003103570A9 Transcutaneous immunization against papillomavirus with papillomavirus virus-like particles |
| 05/06/2004 | WO2003102154A3 Improved receptor detection |
| 05/06/2004 | WO2003102141A3 Identification of a gene causing the most common form of bardet-biedl syndrome and uses thereof |
| 05/06/2004 | WO2003100028A3 Tr2, tr4, tr2/tr4 double knockouts and uses thereof |
| 05/06/2004 | WO2003099997A3 Methods and compositions for regulation and manipulation of steroidogenesis |
| 05/06/2004 | WO2003093480A3 Immortalized hypothalamic neuronal cell lines |
| 05/06/2004 | WO2003093413A3 Barnacle adhesion proteins |
| 05/06/2004 | WO2003086470A3 Smac-peptides as therapeutics against cancer and autoimmune diseases |
| 05/06/2004 | WO2003079966A3 Photo-active backbone cyclized somatostatin analogs for photodynamic therapy and imaging |
| 05/06/2004 | WO2003078572A3 Therapeutic polypeptides, nucleic acids encoding same and methods of use |
| 05/06/2004 | WO2003064469A8 Regulation of human hematopoietin receptor-like protein |
| 05/06/2004 | WO2003062407A8 INFECTIOUS cDNA CLONES OF PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS AND EXPRESSION VECTORS THEREOF |
| 05/06/2004 | WO2003057156A3 Epithelial cell lines from gene knockout mice and methods of use thereof |
| 05/06/2004 | WO2003048186B1 Surface simulation synthetic peptides useful in the treatment of hyper-variable viral pathogens |
| 05/06/2004 | WO2003027148A8 Disulfide-reduced neogalactosyl serum albumin and use of radiolabeled derivative thereof for liver imaging |
| 05/06/2004 | WO2003022298A3 Use of a protein of the crmp family for treating diseases related to the immune system |
| 05/06/2004 | WO2003020016A3 SEED SPECIFIC 7S α PROMOTER FOR EXPRESSING GENES IN PLANTS |
| 05/06/2004 | WO2003016351B1 N - cam related compounds modulating cell groth |
| 05/06/2004 | WO2003011903A3 Identification of specific tumor antigens by means of the selection of cdna libraries with sera |
| 05/06/2004 | WO2003010314A3 Gmg-2 polynucleotides and polypeptides and uses thereof |
| 05/06/2004 | WO2002098456A3 Antigens and vectors for vaccination |
| 05/06/2004 | WO2002092788A9 Cytotoxic peptides and peptidomimetics based thereon, and methods for use thereof |
| 05/06/2004 | WO2002088173A3 Viral-mediated delivery and in vivo expression of polynucleotides encoding anti-angiogenic proteins |
| 05/06/2004 | WO2002087510A3 Subcellular targeting of therapeutic proteins |
| 05/06/2004 | WO2002085389A9 A non-lethal method for extracting crude hemocyanin from gastropod molluscs |
| 05/06/2004 | WO2002083857A3 68723, sodium/glucose cotransporter family members and uses therefor |
| 05/06/2004 | WO2002074914A3 Chemokines and methods for inducing the differentiation of fibroblasts to myofibroblasts |
| 05/06/2004 | WO2002074787A3 Compositions and methods for identifying, characterizing, optimizing and using ligands to transcytotic molecules |
| 05/06/2004 | WO2002072017A9 Method of drug target validation |
| 05/06/2004 | WO2002068462A9 Internal standard for electrophoretic and chromatographic separation processes |
| 05/06/2004 | WO2002066502A8 Helicobacter pylori sialic acid binding adhesin, saba and saba - gene |
| 05/06/2004 | WO2002062827A3 Improved protein disaggregation and refolding using high pressure |
| 05/06/2004 | WO2002061113A9 Nucleic acid derived vaccine that encodes an antigen linked to a polypeptide that promotes antigen presentation |
| 05/06/2004 | WO2002055558A8 Novel proteins and nucleic acids encoding same |
| 05/06/2004 | WO2002038108A3 Methods of treating disorders related to apoe |
| 05/06/2004 | US20040088766 Genes regulating circadian clock function and photoperiodism |
| 05/06/2004 | US20040088763 Comprises nucleotide sequences coding protein which induces flowering in plants; genetic engineering and rice yields |
| 05/06/2004 | US20040088762 Comprises DNA for identification of nucleotide sequences associated with miniaturization of plants; insect resistance |
| 05/06/2004 | US20040088761 Gene concerning brassinosteroid-sensitivity of plants and utilization thereof |
| 05/06/2004 | US20040088760 Comprises nucleotide sequences coding promoter elements associated with chlorophyllous and/or embryonic seed tissue specific expression of heterologous proteins in cotton; bioreactors |
| 05/06/2004 | US20040088756 Identifying diseases resistance gene in plants |
| 05/06/2004 | US20040088755 Inhibitors of plant peptide deformylase for use as broad -spectrum herbicides and methods for identifying the same |
| 05/06/2004 | US20040088749 Comprises restoration of fertility (RF) polypeptide comprising pentatricopeptide repeat (PPR) for restoring fertility to male sterile plants; genetic engineering and selective plant breeding |
| 05/06/2004 | US20040088746 Apoptosis-inducing dna sequences |
| 05/06/2004 | US20040088745 Using expression vector coding heterologous gene associated with sex determination to generate animal models of preferential sex; veterinary medicine; animal husbandry; in vitro fertilization |
| 05/06/2004 | US20040088744 Fatty liver disease resistant bovines |
| 05/06/2004 | US20040088743 Non-human transgenic animal expressing ca-ahr |
| 05/06/2004 | US20040087784 Neuronal serine-threonine protein kinase |
| 05/06/2004 | US20040087783 Comprises nucleotide sequences coding tyrosine kinase for treatment, diagnosis and screening cell proliferative disorders |
| 05/06/2004 | US20040087778 Modified peptides as therapeutic agents |
| 05/06/2004 | US20040087776 Methods for producing factor VIII proteins |
| 05/06/2004 | US20040087775 Process for production diphtheria toxin |
| 05/06/2004 | US20040087774 Comprises tumor necrosis factor receptor associated factor-(TRAF) inhibitor for diagnosis, prevention and tratment of tumors associated wit h epstein-barr virus |
| 05/06/2004 | US20040087773 Molecules for disease detection and treatment |
| 05/06/2004 | US20040087772 Tumor marker polypeptide for diagnosis, prevention and treatment of cell proliferative disorders; antitumor/anticarcinogenic agents |
| 05/06/2004 | US20040087771 Antimicrobial peptides of the family of defensins, polynucleotides encoding said peptides, transformed vectors and organisms containing them |
| 05/06/2004 | US20040087770 Viral peptide for use in diagnosing, preventing and treating sepsis and meningitis; microbiocides; vaccine development |
| 05/06/2004 | US20040087769 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 05/06/2004 | US20040087766 Interleukins; fusion proteins; solid phase synthesis; kits |
| 05/06/2004 | US20040087765 Peptides, the production and use thereof for binding immunoglobulins |
| 05/06/2004 | US20040087538 Nucleic acids containing unmethylated cytosine-guanine dinucleotides activate lymphocytes and redirect an immune response from th2 to th1 |
| 05/06/2004 | US20040087537 Compositions comprising fusion polypeptides HIV-Nef and NGF, and methods of using the same |
| 05/06/2004 | US20040087530 SOCS-3 inhibition; increased leptin cell transduction signal-ing; obesity |
| 05/06/2004 | US20040087525 Polypeptide-human rna binding protein 19 and the polynucleotide encoding it |
| 05/06/2004 | US20040087524 Agent for postoperative use after removal of bone tumours |
| 05/06/2004 | US20040087521 Nucleic acid pharmaceuticals-influenza matrix |